Full Papers
doi.org/10.1002/ejoc.202001418
°
1749, 1676, 1448, 1388, 1244, 1100, 1027, 865. HRMS (EI): calcd. for
C21H32O4S1Si1 408.1791 [M]+, found: 408.1798.
0.14 mmol, 2.0 equiv.) were dissolved in 5 mL dry DCM at 0 C and
stirred for 16 h while the reaction reached room temperature. All
volatile compounds were removed in vacuo. The crude was purified
by flash silica gel column chromatography (PE:EE 3:1) to yield 45
1
2
3
4
5
6
7
8
9
4-((Tert-butyldimethylsilyl)oxy)-6’,6’-dimethylspiro[cyclohexane-
1,2’-[1,3]dioxolo[4’,5’:4,5]benzo[1,2-d][1,3]oxathiole]-4’,8’-dicar-
baldehyde (44a): n-BuLi (0.41 mL, 2.5 M in hexane, 1.03 mmol,
2.1 equiv.) was added to a mixture of TMEDA (0.15 mL, 0.98 mmol,
2.0 equiv.) and 43 (200 mg, 0.49 mmol, 1.0 equiv.) dissolved in 8 mL
dry hexane. The reaction was stirred for 1 h at room temperature.
Dry DMF (0.10 mL, 1.22 mmol, 2.5 equiv.) was added and stirred for
further 30 minutes. The reaction was quenched with saturated
NH4Cl-solution and the phases were separated. The water layer was
extracted with ethyl acetate (2×20 mL) and the combined organic
layers washed with brine, dried over MgSO4 and evaporated. After
purification by flash silica gel column chromatography (PE:EE 10:1)
44a (80 mg, 0.17 mmol, 35%) was isolated as a red oil. Rf (PE:EE/
10:1): 0.35. 1H-NMR (400 MHz, CDCl3, ppm): 10.23 (s, 1 H), 10.18 (s, 1
H), 3.96 (s, 1 H), 1.96–1.79 (m, 14 H), 0.91 (s, 9 H), 0.08 (s, 6 H). 13C-
NMR (101 MHz, CDCl3, ppm): 186.3, 186.0, 150.0, 145.9, 123.9, 116.0,
110.4, 100.2, 66.3, 31.2, 31.0, 30.9, 30.8, 25.9, 18.2, À 4.7. IR (ATR,
cmÀ 1): 2952, 2929, 2855, 1680, 1458, 1375, 1265, 1089, 1055, 1020.
HRMS (EI): calcd. for C23H32O6S1Si1 464.1689 [M]+, found: 464.1683.
1
(27 mg, 0.06 mmol, 88%) as a red oil. Rf (PE:EE/3:1): 0.52. H-NMR
(400 MHz, CDCl3, ppm): 10.21 (s, 1 H), 10.18 (s, 1 H), 4.97–4.86 (m, 1
H), 4.74 (s, 2 H), 2.55 (t, 4J=2.4 Hz, 1 H), 2.22–1.97 (m, 8 H), 1.87 (s, 6
H). 13C-NMR (101 MHz, CDCl3, ppm): 186.2, 185.7, 154.0, 145.4, 145.3,
122.5, 117.6, 116.1, 110.4, 100.4, 77.0, 75.9, 73.3, 72.8, 55.4, 31.0,
30.8, 30.7, 27.5, 27.3. IR (ATR, cmÀ 1): 2924, 2853, 1745, 1676, 1456,
1374, 1250, 1216, 1085. HRMS (EI): calcd. for C21H20O8S1 432.0873
[M]+, found: 432.0878.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
4-((4’,8’-Diformyl-6’,6’-dimethylspiro[cyclohexane-1,2’-[1,3]dioxo-
lo-[4’,5’:4,5]benzo[1,2-d][1,3]oxathiol]-4-yl)oxy)-4-oxobutanoic
acid (46): A suspension of 44b (100 mg, 0.29 mmol, 1.0 equiv.),
succinic anhydride (285 mg, 2.85 mmol, 10.0 equiv.), dry pyridine
(0.12 mL, 1.43 mmol, 5.0 equiv.) and a spatula-tip of DMAP in 10 mL
dry DCM was stirred for 14 h at room temperature. Water (10 mL)
was added and the phases were separated. The organic layer was
washed with saturated NaHCO3-solution (2×20 mL), 1 M HCl (2×
20 mL), dried over MgSO4 and concentrated under reduced
pressure. Purification via flash silica gel column chromatography
gave 46 (81 mg, 0.18 mmol, 64%) as a red oil. Rf (PE:EE/1:1): 0.15.
1H-NMR (400 MHz, CDCl3, ppm): 10.22 (s, 1 H), 10.17 (s, 1 H), 5.01 (s,
Additionally 20% of [1,3]dioxolo[4’,5’:4,5]benzo[1,2-d][1,3]oxa-
thiole]-8’-carbaldehyde and 15% of 4-((tert-butyldimethylsilyl)oxy)-
6’,6’-dimethylspiro[cyclohexane-1,2’-[1,3]dioxolo[4’,5’:4,5]benzo[1,2-
d][1,3]oxathiole]-4’-carbaldehyde were collected:
1 H), 2.66 (t, J=6.0 Hz, 4 H), 2.22–1.95 (m, 8 H), 1.85 (s, 6 H). 13C-
3
NMR (101 MHz, CDCl3, ppm): 186.4, 186.3, 185.7, 171.8, 150.4, 145.5,
145.3, 123.0, 117.5, 116.1, 110.4, 100.4, 69.3, 68.7, 31.3, 30.8, 29.4,
27.5, 27.3. IR (ATR, cmÀ 1): 3362, 2967, 2866, 1710, 1678, 1266, 1206,
1170, 1085, 1010, 730. HRMS (EI): calcd. for C21H22O9S1 450.0985
[M]+, found: 450.0982.
4-((Tert-butyldimethylsilyl)oxy)-6’,6’-dimethylspiro[cyclohexane-
1,2’-[1,3]dioxolo[4’,5’:4,5]benzo[1,2-d][1,3]oxathiole]-8’-carbalde-
hyde: Rf (PE:EE/10:1): 0.42. 1H-NMR (400 MHz, CDCl3, ppm): 10.19 (s,
1 H), 6.52 (s, 1 H), 3.96 (s, 1 H), 1.80 (s, 14 H), 0.88 (s, 9 H), 0.06 (s, 6
H). 13C-NMR (101 MHz, CDCl3, ppm): 186.3, 149.4, 146.0, 145.6, 121.6,
113.5, 99.5, 98.2, 66.11, 31.2, 30.5, 29.9, 27.3, 25.8, 18.4, À 4.7. IR
(ATR, cmÀ 1): 2951, 2929, 2855, 1679, 1462, 1375, 1278, 1096, 1053,
1017. HRMS (EI): calcd. for C22H32O5S1Si1 436.1740 [M]+, found:
436.1733.
4’,8’-Diformyl-6’,6’-dimethylspiro[cyclohexane-1,2’-[1,3]dioxolo-
[4’,5’:4,5]benzo[1,2-d][1,3]oxathiol]-4-yl (2,5-dioxopyrrolidin-1-yl)
succinate (47): 46 (50 mg, 0.11 mmol, 1.0 equiv.), EDC (30 mL,
0.17 mmol, 1.5 equiv.) and N-hydroxysuccinimide (20 mg,
0.17 mmol, 1.5 equiv.) was dissolved in 5 mL dry DCM and stirred
for 16 h at room temperature. DCM (10 mL) was added and the
organic mixture was washed with brine (2×20 mL), saturated
NaHCO3-solution (1×20 mL), Brine (1×20 mL) and dried over
MgSO4. Purification by flash silica gel column chromatography
obtained 47 (52 mg, 0.09 mmol, 85%) as a red solid, m.p. 164–165.
4-((Tert-butyldimethylsilyl)oxy)-6’,6’-dimethylspiro[cyclohexane-
1,2’-[1,3]dioxolo[4’,5’:4,5]benzo[1,2-d][1,3]oxathiole]-4’-carbalde-
1
hyde: Rf (PE:EA 10:1): 0.55. H-NMR (400 MHz, CDCl3, ppm): 10.13
(s, 1 H), 6.70 (s, 1 H), 3.91 (s, 1 H), 1.91–1.82 (m, 14 H), 0.90 (s, 9 H),
0.07 (s, 6 H). 13C-NMR (101 MHz, CDCl3, ppm): 185.5, 143.0, 141.9,
138.7, 121.5, 116.9, 108.0, 100.2, 94.8, 31.3, 31.0, 30.7, 30.4, 25.9,
18.2, À 4.7. IR (ATR, cmÀ 1): 2952, 2929, 2856, 1717, 1468, 1376, 1292,
1251, 1101, 1006. HRMS (EI): calcd. for C22H32O5S1Si1 436.1740 [M]+,
found: 436.1735.
1
Rf (PE:EE/1:1): 0.43. H-NMR (400 MHz, CDCl3, ppm): 10.24 (s, 2 H),
10.18 (s, 1 H), 5.04 (s, 1 H), 3.00–2.76 (m, 8 H), 2.10–1.88 (m, 8 H),
1.86 (s, 6 H). 13C-NMR (101 MHz, CDCl3, ppm): 186.2, 185.9, 170.4,
169.0, 167.8, 150.4, 145.5, 145.4, 122.7, 117.5, 116.0, 110.4, 100.4,
69.9, 69.3, 31.5, 30.7, 29.8, 29.1, 27.5, 26.5, 25.8. IR (ATR, cmÀ 1): 2923,
2852, 1726, 1675, 1457, 1372, 1268, 1203, 1084. HRMS (EI): calcd. for
C25H25O11N1S1 547.1148 [M]+, found: 547.1152.
4-Hydroxy-6’,6’-dimethylspiro[cyclohexane-1,2’-[1,3]dioxolo-
[4’,5’:4,5]benzo[1,2-d][1,3]oxathiole]-4’,8’-dicarbaldehyde (44b):
44a (100 mg, 0.22 mmol, 1.0 equiv.) and HF (10 mL, 0.23 mmol,
1.1 equiv.) were dissolved in a mixture of 4 mL ACN/THF (3:1) and
stirred for 14 h at room temperature. The reaction was quenched
with saturated NaHCO3-solution. The red solution was extracted
with DCM (3×20 mL) and the combined organic layers dried over
MgSO4 and concentrated in vacuo. Purification by flash silica gel
4’,8’-Diformyl-6’,6’-dimethylspiro[cyclohexane-1,2’-[1,3]dioxolo-
[4’,5’:4,5]benzo[1,2-d][1,3]oxathiol]-4-yl 4-((2-(2,5-dioxo-2,5-dihy-
dro-1H-pyrrol-1-yl)ethyl)amino)-4-oxobutanoate (48): Compound
47 (50 mg, 0.09 mmol, 1.0 equiv.), DIPEA (32 μL, 0.18 mmol,
2.0 equiv.) and (2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethan-1-aminio
trifluoroacetate (35 mg, 0.14 mmol, 1.5 equiv.) were dissolved in
5 mL dry DMF and stirred for 14 h at room temperature. All volatile
compounds were removed in vacuo and the residue purified by
flash silica gel column chromatography (DCM:MeOH 50:1) to yield
°
column chromatography (PE:EE 1:1) gave 44b (75 mg, 0.22 mmol,
1
°
quant.) as a red solid, m.p. 156–157 C. Rf (PE:EE/1:1): 0.18. H-NMR
(400 MHz, CDCl3, ppm): 10.23 (s, 1 H), 10.18 (s, 1 H), 3.98 (s, 1 H),
2.05–1.99 (m, 6 H), 1.87–1.82 (m, 8 H). 13C-NMR (101 MHz, CDCl3,
ppm): 186.4, 185.9, 150.3, 145.7, 145.6, 123.3, 117.2, 116.1, 110.4,
100.3, 66.8, 31.6, 31.0, 30.8. IR (ATR, cmÀ 1): 3428, 2932, 2862, 1676,
1456, 1369, 1261, 1136, 1087, 1013. HRMS (EI): calcd. for C17H18O6S1
350.0824 [M]+, found: 350.0826.
48 (34 mg, 0.06 mmol, 65%) as
a red solid, m.p. 92 C. Rf
(DCM:MeOH/25:1): 0.20. 1H-NMR (300 MHz, CDCl3, ppm): 10.22 (s, 1
3
H), 10.18 (s, 1 H), 6.73–6.71 (m, 2 H), 4.14 (q, J=7.1 Hz, 1H), 3.50–
3.33 (m, 4 H), 2.66–2.43 (m, 4 H), 2.24–1.93 (m, 8 H), 1.87 (s, 6 H).
13C-NMR (101 MHz, CDCl3, ppm): 186.3, 185.8, 173.1, 172.4, 171.8,
171.0, 150.4, 145.5, 145.4, 134.4, 134.3, 122.8, 117.5, 116.1, 110.4,
100.4, 60.8, 51.9, 39.6, 38.3, 36.0, 34.9, 30.8, 29.8, 27.5, 14.3. IR (ATR,
cmÀ 1): 2926, 2854, 1702, 1438, 1369, 1265, 1203, 1084. HRMS (ESI):
calcd. for C27H29N2O10S1 573.1543 [M+H]+, found: 573.1537.
4’,8’-Diformyl-6’,6’-dimethylspiro[cyclohexane-1,2’-[1,3]dioxolo-
[4’,5’:4,5]benzo[1,2-d][1,3]oxathiol]-4-yl ethynyl carbonate (45):
Alcohol 44b (25 mg, 0.07 mmol, 1.0 equiv.), dry pyridine (18 μL,
0.14 mmol, 2.0 equiv.) and propargyl chloroformate (20 mL,
Eur. J. Org. Chem. 2021, 499–511
510
© 2020 The Authors. European Journal of Organic Chemistry published
by Wiley-VCH GmbH